Clinical Trials of Poly(ADP-Ribose) Polymerase Inhibitors for Cancer Therapy: A Review

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|10|4|326-339

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.10, Iss.4, 2015-12, pp. : 326-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QSAR studies of phthalazinones: novel inhibitors of poly (ADP-ribose) polymerase

By Rewatkar Prarthana  

Medicinal Chemistry Research, Vol. 20, Iss. 7, 2011-09 ,pp. : 877-886

Springer Publishing Company

Access to resources Recommend Favorite

The world according to poly(ADP-ribose) polymerase (PARP)—update 2006

By Barth Eberhard   Radermacher Peter   Szabó Csaba  

Intensive Care Medicine, Vol. 32, Iss. 10, 2006-10 ,pp. : 1470-1474

Springer Publishing Company

Access to resources Recommend Favorite

Autoantibodies to Poly(ADP-Ribose) Polymerase in Centenarians: A Reappraisal of Grabar’s Hypothesis

By  

Gerontology, Vol. 55, Iss. 4, 2009-04 ,pp. : 427-429

Karger

Access to resources Recommend Favorite

Pretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarct

By          

International Journal of Molecular Medicine, Vol. 31, Iss. 1, 2013-01 ,pp. : 26-32

Spandidos Publications

Access to resources Recommend Favorite

Poly(ADP-ribose) polymerase-1 in high glucose-induced epithelial-mesenchymal transition during peritoneal fibrosis

By            

International Journal of Molecular Medicine, Vol. 29, Iss. 3, 2012-01 ,pp. : 472-478

Spandidos Publications

Access to resources Recommend Favorite